Therapeutic receptor targets for lower urinary tract dysfunction.
about
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategiesNeural mechanisms underlying lower urinary tract dysfunctionHow does the urothelium affect bladder function in health and disease? ICI-RS 2011Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introductionTRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injuryEmerging Families of Ion Channels Involved in Urinary Bladder Nociception.Neuropeptides in lower urinary tract functionEffects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladderDifferential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats.Pelvic floor muscles and the external urethral sphincter have different responses to applied bladder pressure during continence.Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study.Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity.Role of Purinergic Signaling in Voiding Dysfunction.Prospective pharmacologic therapies for the overactive bladderOveractive bladder in malesRole of KIT-Positive Interstitial Cells of Cajal in the Urinary Bladder and Possible Therapeutic Target for Overactive BladderFunctional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels.Control of urinary drainage and voiding.Role of Nicotinic Acetylcholine Receptor α3 and α7 Subunits in Detrusor Overactivity Induced by Partial Bladder Outlet Obstruction in Rats.Quantitative evaluation of CART-containing cells in urinary bladder of rats with renovascular hypertensionModulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptors.Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.Diabetic plasticity of non-adrenergic non-cholinergic and P2X-mediated rat bladder contractionsNetupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-PigsGene expression of muscarinic, tachykinin, and purinergic receptors in porcine bladder: comparison with cultured cells.The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures.Basic mechanisms of urgency: roles and benefits of pharmacotherapyPurinergic signalling in the urinary tract in health and disease.Bladder afferent signaling: recent findings.From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.Neurophysiology and therapeutic receptor targets for stress urinary incontinence.Use of mirabegron in treating overactive bladder.Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity.Neurotrophins in bladder function: what do we know and where do we go from here?Central nervous targets for the treatment of bladder dysfunction.Urothelium update: how the bladder mucosa measures bladder filling.Platelet-derived growth factor receptor-α cells in mouse urinary bladder: a new class of interstitial cellsInhibition of urothelial P2X3 receptors prevents desensitization of purinergic detrusor contractions in the rat bladder.Functional and molecular changes of the bladder in rats with crushing injury of nerve bundles from major pelvic ganglion to the bladder: role of RhoA/Rho kinase pathwayInvestigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder.
P2860
Q26767297-E5049DEB-4ECC-4F93-A18C-08CD028D7529Q26852088-CA876355-7C01-409C-9EAC-9FAF409EFE1FQ27010351-347BAD89-6706-475D-BCF2-323C7478A1D6Q27011502-EE3B8A1C-D5D8-48B5-A34A-F8F690384315Q28564612-7B0CCD2E-FDC4-48E0-B9FA-D2876096F6ECQ33677969-61C2C561-D795-4755-8B16-7338C765237CQ33693944-A0015805-B395-48AB-8246-93A396188CC2Q33841023-A0C40AFB-9E90-4F39-B228-99318CE545F8Q33853947-AFB39636-A592-4A0A-A4E4-1F2BC8880B17Q33888992-773DA4FD-8A1C-4D70-8903-23DF8D78874DQ33953840-B367708C-DF4A-4B9B-8712-D0D31EB8E29AQ33972580-8243C927-0AEA-4D32-AC40-B2713447BFBDQ34973917-7E084F98-225B-43AC-AA42-B043F2E9C3B2Q35076367-7600AC03-5161-4995-8DEB-A5E4D8D05009Q35076391-F96891B7-E051-4205-B5CC-EB262E103D95Q35116336-64F7D9E6-0B79-4F91-97FF-C84EEBFF0F51Q35130556-3A0C1D01-EEDF-4161-B027-D2DD37E7178EQ35144401-12CC5B78-177F-4568-8A6E-4EAA779E1D99Q35281118-B25C77BE-C9C5-43C5-9469-D6376136B734Q35856431-1468FFBC-C295-43BB-8A1B-555C6B4C340BQ35955766-7E771318-2920-470F-B017-1834212ED059Q36388886-3564062D-2297-405C-8A59-A5762CFC892BQ36925548-24AD33AE-3219-4D31-A113-FA3F6EB57BFCQ37150382-9C7C386F-0687-4A39-ABA6-E9D0C8856071Q37348576-EE1E2B73-46DA-4027-8BE1-D570711C8E1FQ37372013-9642D2DA-EF73-46B4-8914-F754089C1509Q37428717-3DE7BF0E-E561-4174-8150-3C1F6876263BQ37620260-AD6237C5-4780-4CAC-A97C-118720833537Q37695617-BE85F0C2-340E-42E7-8729-85D706B9D3D8Q37942411-1B5D5DA9-1F87-47C7-9A7A-DC928E20945DQ37992131-D8AC79EF-5A62-4F99-9C1C-B2EAF43DA334Q37992887-2F0A9FB5-F690-4087-8FE3-CB163C291FBDQ38022106-F4702950-96FE-4897-B287-B706C592A451Q38115263-62176479-304F-425D-B158-52B3CC7D1CACQ38119899-C331814C-2F8D-49A3-BB53-C01DE76BB086Q38996469-36FF9F2D-6E2D-47E3-92B4-E34D414F67A0Q41821535-C33E3306-2A43-4E35-9093-65AD199E2F20Q42469009-7F8C206A-13FE-4216-A303-F60746AB7931Q42663748-A0236A96-E776-4DF6-B419-C4104FDAEAB3Q46103322-6DBD4B2F-42B0-4EB0-B274-3C5592FD4077
P2860
Therapeutic receptor targets for lower urinary tract dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Therapeutic receptor targets for lower urinary tract dysfunction.
@en
Therapeutic receptor targets for lower urinary tract dysfunction.
@nl
type
label
Therapeutic receptor targets for lower urinary tract dysfunction.
@en
Therapeutic receptor targets for lower urinary tract dysfunction.
@nl
prefLabel
Therapeutic receptor targets for lower urinary tract dysfunction.
@en
Therapeutic receptor targets for lower urinary tract dysfunction.
@nl
P2093
P2860
P1476
Therapeutic receptor targets for lower urinary tract dysfunction.
@en
P2093
Changfeng Tai
Michael B Chancellor
Minoru Miyazato
Naoki Yoshimura
Pradeep Tyagi
Takakazu Yunoki
Yasuhiro Kaiho
P2860
P2888
P304
P356
10.1007/S00210-007-0209-Z
P577
2007-11-21T00:00:00Z